Respiratory Syncytial Virus Vaccines for the Prevention of Lower Respiratory Tract Infections in Patients Living with Chronic Obstructive Pulmonary Disease: A Rapid Review

Background: Patients living with chronic obstructive pulmonary disease (COPD) are at risk for lower respiratory tract infections caused by respiratory syncytial virus (RSV). The first RSV vaccines were approved in 2023 for adults ages 60 years and older. The safety and efficacy of the RSV vaccines a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Paul M. Boylan, Megan E. Fleischman, Nathan Pinner, Joseph Andrew Woods, Adam Welch
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-01-01
coleção:	Biologics
Assuntos:	respiratory syncytial virus vaccines respiratory syncytial virus respiratory tract infections chronic obstructive pulmonary disease
Acesso em linha:	https://www.mdpi.com/2673-8449/4/1/2
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!